SF3B1 and glioblastoma: Most notably, SF3B1 blockade strikingly decreased also GBM-stem/progenitor cells in terms of tumorspheres number and area, both relevant functional results that may help to explore the GBM onset and how to overcome the well-known GBM -resistance to different/current drugs [21, 51].